GLIMSER P1

Glimser-P1 Tablet SR is a therapeutic formulation designed to assist in regulating blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. It is intended for use as part of a broader treatment regimen that includes a balanced diet and regular physical activity, enhancing overall glycemic control. The active components of Glimser-P1 facilitate the effective use of insulin in the body, which plays a critical role in reducing elevated blood sugar levels. It is essential for patients to adhere to the prescribed dosage and duration specified by their healthcare provider. To minimize gastrointestinal discomfort, this medication should be taken in conjunction with food. In the event of a missed dose, it is advisable to take it promptly unless it is close to the time for the subsequent dose; in such cases, the missed dose should be omitted to maintain the established dosing schedule, avoiding any double dosing. Care must be taken, as an overdose may result in hypoglycemia, characterized by dangerously low blood sugar levels. Individuals using Glimser-P1 may experience hypoglycemia, particularly when combined with other antidiabetic treatments, alcohol consumption, or missed meals. Regular monitoring of blood sugar levels is recommended during therapy. Additional potential side effects include nausea, abdominal discomfort, diarrhea, headaches, fractures, and respiratory infections. Prior to commencing treatment, it is crucial to inform your healthcare provider of any existing kidney, liver, or cardiovascular conditions. Pregnant or breastfeeding individuals should seek medical advice before starting this medication. Routine kidney function tests may be performed by your healthcare provider to ensure safety during treatment, and it is advisable to limit alcohol intake to reduce the risk of adverse effects.